Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
Investment will fund expansion to meet rising demand for CRDMO services
Acquisition expands high-value medical platform
The biosimilar Ustekinumab has been developed and manufactured by the company
The company uses iPS cells to develop treatments for diseases relating to the kidney
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
He holds a Master’s in Management from the National University of Singapore
Subscribe To Our Newsletter & Stay Updated
